Morgan Partners Global Investors Selldown L P JP II's Net Worth

$1.75 Billion

Estimate Recalculated Jul 12, 2024 03:34PM EST

Who is Morgan Partners Global Investors Selldown L P JP II?

Morgan Partners Global Investors Selldown L P JP II has an estimated net worth of $1.75 Billion. This is based on reported shares across multiple companies, which include PHARMOS CORP, Aramark, Emergent BioSolutions Inc., Kraton Performance Polymers, Inc., and SEATTLE GENETICS INC /WA.

SEC CIK

Morgan Partners Global Investors Selldown L P JP II's CIK is 0001361608

Past Insider Trading and Trends

2007 was Morgan Partners Global Investors Selldown L P JP II's most active year for acquiring shares with 8 total transactions. Morgan Partners Global Investors Selldown L P JP II's most active month to acquire stocks was the month of January. 2008 was Morgan Partners Global Investors Selldown L P JP II's most active year for disposing of shares, totalling 32 transactions. Morgan Partners Global Investors Selldown L P JP II's most active month to dispose stocks was the month of April. 2007 saw Morgan Partners Global Investors Selldown L P JP II paying a total of $0.00 for 2,045,000 shares, this is the most they've acquired in one year. In 2015 Morgan Partners Global Investors Selldown L P JP II cashed out on 26,532,756 shares for a total of $824,329,338.96, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PHARMOS CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
—
0
—
—
0
Jan 23
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Jan 23
Form 4/A
—
0
—
—
0
Jan 17
Form 3
—
0
—
—
0
No matching records found

Aramark (ARMK) Snapshot price: $29.015

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-6.23M
$30.98
-$192,872,805.60
0
Jul 1
Form 4
-54.64%
-7.50M
$31.47
-$236,025,000.00
6.23M
May 27
Form 4
-28.96%
-5.60M
$32.16
-$179,945,040.96
13.73M
Mar 26
Form 4
-27.18%
-7.21M
$29.88
-$215,486,492.40
19.32M
Feb 23
Form 4
-23.81%
-8.29M
$27.02
-$224,090,153.84
26.53M
Dec 17
Form 4
-12.64%
-5.04M
$24.54
-$123,686,614.78
34.83M
Jun 4
Form 4
-5.98%
-2.53M
$18.90
-$47,898,799.20
39.87M
Dec 17
Form 3
—
0
—
—
0
No matching records found

Emergent BioSolutions Inc. (EBS) Snapshot price: $1.515

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Kraton Performance Polymers, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

SEATTLE GENETICS INC /WA (SGEN) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.20%
-21.50K
$10.36
-$222,740.00
1.77M
Jul 25 - Jul 28
Form 4
-7.94%
-150.00K
$10.81
-$1,621,500.00
1.74M
Jul 25
Form 4
-5.57%
-122.89K
$10.10
-$1,241,219.30
2.08M
May 14
Form 4
-2.28%
-51.54K
$10.06
-$518,452.16
2.2M
May 13
Form 4
—
0
—
—
0
May 25
Form 4
+0.05%
270
$8.57
-$17,266,236.10
522.22K
Feb 9
No matching records found